טוען...
Insulin-like growth factor- I and factors affecting it in thalassemia major
Despite improvement of blood transfusion regimens and iron chelation therapy growth and maturational delay, cardiomyopathy, endocrinopathies and osteoporosis still occur in good number of thalassemic patients. Decreased IGF-1 secretion occurs in the majority of the thalassemic patients particularly...
שמור ב:
| הוצא לאור ב: | Indian J Endocrinol Metab |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Medknow Publications & Media Pvt Ltd
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4319264/ https://ncbi.nlm.nih.gov/pubmed/25729686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.131750 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|